Lubiprostone has been on pharmacy shelves for nearly two decades, prescribed to help people with stubborn constipation.

Kidney disease treatment is undergoing a transformation, driven by exciting new research that reveals the protective power of semaglutide in patients with type 2 diabetes. Semaglutide, a medication ...

The drug finerenone has a positive effect on patients with type 1 diabetes and chronic kidney disease. The drug reduces the amount of proteins excreted in the urine of these patients. This reduction ...

SGLT2 inhibitors (gliflozins) were developed as oral antidiabetics. They enhance urinary glucose excretion by inhibiting SGLT-2 (sodium-dependent glucose co-transporter-2) in the renal tubuli. The ...

A meta-analysis showed that all doses of tirzepatide, a novel twincretin molecule, reduced albuminuria levels without affecting renal function in patients with type 2 diabetes (T2D). There was ...

"This is the first GLP-1 receptor agonists study to show significant reduction in the risk of kidney failure…Our study establishes GLP-1 receptor agonists as an important kidney-protective class of ...

The presence of the M1 genetic variant may confer protection in people with high-risk, APOL1-associated kidney disease, who are predominantly of Black African ancestry, with potentially important ...

Together they are advocating for legislation to protect living organ donors and access to healthcareROCKVILLE, Md., May 06, 2026 (GLOBE NEWSWIRE) -- Thirty-five American Kidney Fund (AKF) Ambassadors ...

Women and female mice are better able to recover from acute kidney injury (AKI) than are men and male mice, but the reasons for this hasn’t been well understood. The results of a murine study led by ...